4IPH fundamentals
INNATE PHARMA financial statements, including revenue, expenses, profit, and loss
The total revenue of 4IPH for the last semiannual is 8.29 M EUR, and it's 49.91% lower compared to the previous semiannual. The net income of H1 24 is -24.76 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM